Cantor Fitzgerald Reiterates Overweight Rating for Upexi (NASDAQ:UPXI)

Upexi (NASDAQ:UPXI)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $2.00 target price on the stock. Cantor Fitzgerald’s price target suggests a potential upside of 89.57% from the company’s current price.

Several other brokerages also recently commented on UPXI. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Upexi in a research note on Friday, September 4th. Wall Street Zen raised Upexi from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $5.00.

Upexi Trading Up 0.5%

Shares of NASDAQ UPXI opened at $1.05 on Friday. Upexi has a twelve month low of $0.54 and a twelve month high of $7.75. The stock has a market cap of $83.03 million, a price-to-earnings ratio of -1.70 and a beta of -0.21. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 2.96. The company’s fifty day moving average is $0.92 and its 200-day moving average is $1.03.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Arrington Capital Management LLC bought a new stake in shares of Upexi in the fourth quarter worth $4,637,000. MMCAP International Inc. SPC grew its position in Upexi by 203.4% in the fourth quarter. MMCAP International Inc. SPC now owns 2,326,777 shares of the company’s stock valued at $3,909,000 after purchasing an additional 1,559,844 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Upexi in the fourth quarter valued at $268,000. J. Derek Lewis & Associates Inc. acquired a new stake in Upexi in the 4th quarter valued at $255,000. Finally, Aristides Capital LLC bought a new stake in Upexi during the 4th quarter worth about $100,000. Institutional investors and hedge funds own 5.68% of the company’s stock.

Upexi Company Profile

Upexi, Inc (NASDAQ: UPXI) is a consumer products company that develops, acquires and manages a portfolio of brands sold through e-commerce and other retail channels. Its business focuses on building products with recurring consumer demand and expanding their distribution across marketplaces, direct-to-consumer websites and brick-and-mortar retail.

The company’s portfolio has included brands in categories such as health and wellness, food and beverage, beauty, household products and pet care.